Host immune system modulation in Ph+ acute lymphoblastic leukemia patients treated with dasatinib and blinatumomab

Maria Cristina Puzzolo; Giulia Radice; Nadia Peragine; Maria Stefania de Propris; Paola Mariglia; Marco Vignetti; Antonella Vitale; Renato Bassan; Mario Annunziata; Gianluca Gaidano; Alessandro Rambaldi; Sabina Chiaretti; Anna Guarini; Robin Foà

doi:10.1182/blood.2021011822

Host immune system modulation in Ph⁺ acute lymphoblastic leukemia patients treated with dasatinib and blinatumomab

Maria Cristina Puzzolo
, Giulia Radice
, Nadia Peragine
, Maria Stefania de Propris
, Paola Mariglia
, Marco Vignetti
, Antonella Vitale
, Renato Bassan
, Mario Annunziata
, Gianluca Gaidano
, Alessandro Rambaldi
, Sabina Chiaretti
, Anna Guarini
, Robin Foà

Department of Translational Medicine

Research output: Contribution to journal › Letter › peer-review

Original language	English
Pages (from-to)	2290-2293
Number of pages	4
Journal	Blood
Volume	138
Issue number	22
DOIs	https://doi.org/10.1182/blood.2021011822
Publication status	Published - 2 Dec 2021

Access to Document

10.1182/blood.2021011822

Cite this

Puzzolo, M. C., Radice, G., Peragine, N., de Propris, M. S., Mariglia, P., Vignetti, M., Vitale, A., Bassan, R., Annunziata, M., Gaidano, G., Rambaldi, A., Chiaretti, S., Guarini, A., & Foà, R. (2021). Host immune system modulation in Ph⁺ acute lymphoblastic leukemia patients treated with dasatinib and blinatumomab. Blood, 138(22), 2290-2293. https://doi.org/10.1182/blood.2021011822

@article{c6ff2617e3864e12a8d82c61eaca204c,

title = "Host immune system modulation in Ph+ acute lymphoblastic leukemia patients treated with dasatinib and blinatumomab",

author = "Puzzolo, \{Maria Cristina\} and Giulia Radice and Nadia Peragine and \{de Propris\}, \{Maria Stefania\} and Paola Mariglia and Marco Vignetti and Antonella Vitale and Renato Bassan and Mario Annunziata and Gianluca Gaidano and Alessandro Rambaldi and Sabina Chiaretti and Anna Guarini and Robin Fo{\`a}",

note = "Funding Information: This work was supported by the Associazione Italiana per la Ricerca sul Cancro (AIRC), Metastases 5 × 1000 Special Program, No. 21198, Milan, Italy (R.F.). ",

year = "2021",

month = dec,

day = "2",

doi = "10.1182/blood.2021011822",

language = "English",

volume = "138",

pages = "2290--2293",

journal = "Blood",

issn = "0006-4971",

publisher = "Elsevier B.V.",

number = "22",

}

Puzzolo, MC, Radice, G, Peragine, N, de Propris, MS, Mariglia, P, Vignetti, M, Vitale, A, Bassan, R, Annunziata, M, Gaidano, G, Rambaldi, A, Chiaretti, S, Guarini, A & Foà, R 2021, 'Host immune system modulation in Ph⁺ acute lymphoblastic leukemia patients treated with dasatinib and blinatumomab', Blood, vol. 138, no. 22, pp. 2290-2293. https://doi.org/10.1182/blood.2021011822

TY - JOUR

T1 - Host immune system modulation in Ph+ acute lymphoblastic leukemia patients treated with dasatinib and blinatumomab

AU - Puzzolo, Maria Cristina

AU - Radice, Giulia

AU - Peragine, Nadia

AU - de Propris, Maria Stefania

AU - Mariglia, Paola

AU - Vignetti, Marco

AU - Vitale, Antonella

AU - Bassan, Renato

AU - Annunziata, Mario

AU - Gaidano, Gianluca

AU - Rambaldi, Alessandro

AU - Chiaretti, Sabina

AU - Guarini, Anna

AU - Foà, Robin

N1 - Funding Information: This work was supported by the Associazione Italiana per la Ricerca sul Cancro (AIRC), Metastases 5 × 1000 Special Program, No. 21198, Milan, Italy (R.F.).

PY - 2021/12/2

Y1 - 2021/12/2

UR - https://www.scopus.com/pages/publications/85120354613

U2 - 10.1182/blood.2021011822

DO - 10.1182/blood.2021011822

M3 - Letter

SN - 0006-4971

VL - 138

SP - 2290

EP - 2293

JO - Blood

JF - Blood

IS - 22

ER -

Host immune system modulation in Ph+ acute lymphoblastic leukemia patients treated with dasatinib and blinatumomab

Access to Document

Other files and links

Cite this

Host immune system modulation in Ph⁺ acute lymphoblastic leukemia patients treated with dasatinib and blinatumomab